Thursday, 18 September 2008

Regenerative Injection of Elite Athletes with Career-Altering Chronic Groin Pain

Am J Phys Med Rehabil. 2008 Aug 6.
A Consecutive Case Series.
Topol GA, Reeves KD.

From the Physical Medicine and Rehabilitation Service, Jaime Slullitel Rosario Orthopedic and Trauma Institute, Argentina (GAT); Servicio de Medicina Física y Rehabilitación del Hospital Provincial de Rosario, Argentina (GAT); Team Physiatrist, Rosario Rugby Union, Argentina (GAT); Meadowbrook Rehabilitation Hospital, Gardner, Kansas (KDR); and Department of Physical Medicine and Rehabilitation, University of Kansas Medical Center, Kansas, Kansas (KDR).

Topol GA, Reeves KD: Regenerative injection of elite athletes with career-altering chronic groin pain who fail conservative treatment: a consecutive case series. Am J Phys Med Rehabil 2008. OBJECTIVE:: To obtain multisport and long-term outcome data from use of regenerative injection therapy on career-threatened athletes. DESIGN:: Consecutive enrollment of elite performance-limited athletes with chronic groin/abdominal pain who failed a conservative treatment trial. The treatment consisted of monthly injection of 12.5 dextrose in 0.5% lidocaine in abdominal and adductor attachments on the pubis. Injection of the nociceptive source was confirmed by repetition of resistive testing 5 min after injection. RESULTS:: Seventy-five athletes were enrolled. Seventy-two athletes (39 rugby, 29 soccer, and 4 other) completed the minimum two treatment protocol. Their data revealed a mean groin pain duration of 11 (3-60) mos. Average number of treatments received was 3 (1-6). Individual paired t tests for VAS of pain with sport (VAS Pain) and Nirschl pain phase scale measured at 0 and an average of 26 (6-73) mos indicated VAS Pain improvement of 82% (P < 10), and Nirschl pain phase scale improvement of 78% (P < 10). Six athletes did not improve following regenerative injection therapy treatment and the remaining 66 returned to unrestricted sport. Return to unrestricted sport occurred in an average of 3 (1-5) mos. CONCLUSIONS:: Athletes returned to full elite-level performance in a timely and sustainable manner after regenerative injection therapy using dextrose.

No comments:

Benchmark54

Benchmark54
Football EMR Audit Analytics

Why Advertise with us ?

We have a specific audience of over 600 Sports Physicians Radiologists and Surgeons all working in Sports Medicine the fastest growing medical speciality. Our clients include Arsenal, Liverpool, Everton, Celtic, Tottenham, Aston Villa, The FA, The RFU, The EIS, IMG.. please contact us using the tab above for our rates.

Blog Archive

There was an error in this gadget